↓ Skip to main content
AI Standard of Care
  1. Tags/

AAD Guidelines

Dermatology AI Standard of Care: Skin Cancer Detection, Melanoma Screening, and Liability

··9 mins
Healthcare Dermatology AI Skin Cancer Detection Melanoma DermaSensor FDA Devices Malpractice Standard of Care AAD Guidelines Teledermatology
AI Enters the Skin Cancer Screening Revolution # Skin cancer is the most common cancer in the United States, yet approximately 25% of cases are misdiagnosed. In January 2024, the FDA authorized DermaSensor, the first AI-enabled dermatologic device cleared for use by non-specialists, opening a new frontier for skin cancer detection in primary care settings.